Nielsen BioSciences
San Diego, US · Founded 2013 · Delaware corporation
Nielsen BioSciences is a privately-held biopharmaceutical company that develops and commercializes biological products based on cell-mediated immune responses. Its FDA-approved skin test antigens include CANDIN, used to assess cellular immunity, and SPHERUSOL, used to test for Coccidioides exposure (Valley Fever).
Founders & leadership
SN
Scott NielsenExecutive
NL
Nelson LugoExecutive
TR
Thomas R CarpenterExecutive
HS
Harry Stewart Nielsen, Jr.Named on SEC filing
Board
GJ
Gene J OstrowBoard director
GC
Grover C WrennBoard director
JG
John G RobyBoard director
RE
Robert E EschBoard director
DE
David E Thomas, Jr.Board director
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 2 rounds · 2016–2021
▶$8.4MraisedAug 2021 · 60 investors · BiotechnologyRule 506(b)
▶$8.4MraisedAug 2021 · 60 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DAVID E. THOMAS, JR.Director
- STEWART SCOTT NIELSENExecutive Officer
- HARRY STEWART NIELSEN, JR.Director
- GROVER WRENNExecutive Officer, Director
- JOHN G. ROBYDirector
- DAVID P. BURNEYExecutive Officer
- ROBERT E. ESCHDirector
- BRUCE F. MACKLERDirector
- GENE J. OSTROWDirector
- Offering amount
- $10M
- Amount sold
- $8.4M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedSep 2016 · 65 investors · BiotechnologyRule 506(b)
▶$3.4MraisedSep 2016 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott NielsenExecutive Officer
- Gene J OstrowDirector
- Grover C WrennDirector
- Harry Stewart Nielsen, Jr.Director
- Nelson LugoExecutive Officer
- Thomas R CarpenterExecutive Officer, Director
- John G RobyDirector
- Robert E EschDirector
- David E Thomas, Jr.Director
- Offering amount
- $3.5M
- Amount sold
- $3.4M
- Minimum investment
- $1K
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nielsen BioSciences do?
- Nielsen BioSciences is a privately-held biopharmaceutical company that develops and commercializes biological products based on cell-mediated immune responses. Its FDA-approved skin test antigens include CANDIN, used to assess cellular immunity, and SPHERUSOL, used to test for Coccidioides exposure (Valley Fever).
- How much funding has Nielsen BioSciences raised?
- Nielsen BioSciences has disclosed $11.8M raised across 2 rounds.
- Where is Nielsen BioSciences headquartered?
- Nielsen BioSciences is headquartered in San Diego, US.